Investigation of Hemodynamics and Radiomics Based on High Resolution Magnetic Resonance Imaging for Predicting the Outcomes of Intracranial Dissecting Aneurysm

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07335029

Enrollment

208

Registered

2026-01-12

Start date

2023-01-01

Completion date

2027-12-31

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Disease, Intracranial Aneurysm, Intracranial Arterial Dissection

Brief summary

This study aims to conduct a comprehensive analysis by integrating clinical factors, aneurysm morphological characteristics, and factors reflecting pathophysiological processes (such as hemodynamic and radiomics features), in order to explore the hemodynamic mechanisms associated with the progression of intracranial dissecting aneurysms. Furthermore, artificial intelligence algorithms will be employed to develop and validate an intelligent risk prediction model for the progression and outcomes of intracranial dissecting aneurysms.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. Intracranial dissecting aneurysm clearly diagnosed by DSA and high-resolution MRI imaging (according to the imaging diagnostic criteria proposed in the Chinese Expert Consensus on Imaging Diagnosis of Intracranial Arterial Dissection) 2. patients managed with conservative treatment and follow-up 3. patients who agree and sign a written informed consent form

Exclusion criteria

1. Arteritis, fibromuscular dysplasia, iatrogenic or traumatic pseudoaneurysms 2. Contraindications to MRI examination (such as claustrophobia or metallic implants), or contraindications to cerebral angiography (such as iodine contrast allergy) 3. Dissecting aneurysms extending from the extracranial segment to the intracranial segment, or cases with concomitant intracranial atherosclerotic plaques in the affected vessels 4. Patients who refuse MRI examination 5. Patients with severe comorbid diseases and an expected survival time of less than 2 years due to these conditions 6. Patients without follow-up HR-MRI imaging for any reason

Design outcomes

Primary

Measure	Time frame
Progression of intracranial dissecting aneurysms	From enrollment to 12 months of follow-up

Countries

China

Outcome results